Actinium Pharmaceuticals, Inc. To Present At 2nd Annual Sachs Cancer Bio Partnering & Investor Forum
3/13/2014 6:49:20 AM
Actinium Pharmaceuticals, Inc. (OTCQB:ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announces that Kaushik J. Dave, Ph.D., President and CEO, will present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum at New York Academy of Sciences, located at 250 Greenwich St, New York, NY, on Wednesday, March 19, 2014 at 2:45 PM ET.
Help employers find you! Check out all the jobs and post your
comments powered by